Giuseppe Romeo

13PUBLICATIONS
36CO-AUTHORS
Medical infection agents (incl. prions)Biologically active moleculesSensory systemsCheminformatics and quantitative structure-activity relationshipsNonlinear optics and spectroscopy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 30, 2025
Diroximel Fumarate-Loaded Solid Lipid Nanoparticles (DRF-SLNs) as Potential Carriers for the Treatment of Multiple Sclerosis: Preformulation Study.

Debora Santonocito, Giuliana Greco, Maria Grazia Sarpietro

|May 28, 2022
Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia.

Valeria Ciaffaglione, Valeria Consoli, Sebastiano Intagliata

|Jan 21, 2022
Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer Liabilities of Use.

Lisa L Wilson, Shainnel O Eans, Insitar Ramadan-Siraj

|Sep 02, 2021
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent In Vitro Antiproliferative Activity.

Antonino N Fallica, Valeria Sorrenti, Agata G D'Amico

|Aug 07, 2021
Lipid Nanoparticles Traverse Non-Corneal Path to Reach the Posterior Eye Segment: In Vivo Evidence.

Carmelo Puglia, Debora Santonocito, Giuseppe Romeo

|Jul 02, 2021
Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity.

Giuseppe Romeo, Valeria Ciaffaglione, Emanuele Amata

Pageof 3

Frequent Collaborators

10 joint publications

Sebastiano Intagliata

8 joint publications

Valeria Pittalà

7 joint publications

Loredana Salerno

5 joint publications

Maria N Modica